Metric Finance
LearnFAQ
LearnFAQ

Learn / OLMA

NASDAQ: OLMA

Olema Pharmaceuticals (OLMA) stock, explained like you're 5

Olema Pharmaceuticals trades on the Nasdaq under the ticker OLMA. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 684 million dollars.

Ticker
OLMA
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 684 million dollars

Is Olema Pharmaceuticals a small, medium or large cap company?

No. Olema Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 684 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Olema Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves OLMA stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Olema Pharmaceuticals, Inc. (OLMA) Latest Stock News & Headlines (Yahoo! Finance Canada)
  • A 9.99% ownership cap limits warrant exercises at Olema Pharmaceuticals (OLMA). (Stock Titan)
  • Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock Has Consensus Price Target of $40.60 According to Brokerages (MarketBeat)
  • OLMA Forecast Price Target Prediction for 2027 (TradingView)
  • Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027 (Benzinga)

Follow OLMA in your daily brief

Each trading day at 5 PM ET we post what happened to Olema Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow OLMA

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Olema Pharmaceuticals stock

What does Olema Pharmaceuticals do?

Olema Pharmaceuticals trades on the Nasdaq under the ticker OLMA. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 684 million dollars.

What is the ticker symbol for Olema Pharmaceuticals?

Olema Pharmaceuticals trades under the ticker OLMA on the Nasdaq.

What is Olema Pharmaceuticals's market cap?

Olema Pharmaceuticals is a small cap stock with a market cap of about 684 million dollars.

How does Olema Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves OLMA stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow OLMA stock every day?

Add OLMA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow OLMA daily

A free brief on Olema Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare OLMA: OLMA vs NVS, OLMA vs AZN, OLMA vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed